SCHEMBL979240

SCHEMBL979240

COC(=O)C(O)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.55
ATM Q13315 1/20 0.54
ALDH1A1 P00352 2/20 0.53
THRB P10828 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MEN1 O00255 1/20 0.51
POLB P06746 1/20 0.51
LTA4H P09960 1/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
CA12 O43570 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
LMNA P02545 1/20 0.49
GLA P06280 1/20 0.49
MIF P14174 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3980617 1.00 KMT2A (0.55) KMT2AATMALDH1A1THRBCYP2C9
SCHEMBL180159 1.00 KMT2A (0.55) KMT2AATMALDH1A1THRBCYP2C9
SCHEMBL15446223 0.87 PPARG (0.53) LTA4H
SCHEMBL2164928 0.86 LTA4H (0.72) LTA4HNPC1RAB9AMMP8
SCHEMBL5309375 0.86 LTA4H (0.72) LTA4HNPC1RAB9AMMP8
SCHEMBL6732617 0.86 LTA4H (0.72) LTA4HNPC1RAB9AMMP8
SCHEMBL1245765 0.83 MMP8 (0.59) KMT2AALDH1A1CYP2C9HSD17B10MEN1
SCHEMBL3910015 0.83 ESR1 (0.65) KMT2ANPC1RAB9AMIF
SCHEMBL6284464 0.83 MMP8 (0.59) KMT2AALDH1A1CYP2C9HSD17B10MEN1
SCHEMBL15689792 0.83 ESR1 (0.65) KMT2ANPC1RAB9AMIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4722296-A1 POLYHYDROXYALKANOATE COMPOSITION, POLYHYDROXYALKANOATE MOLDED ARTICLE AND PREPARATION METHOD THEREFOR Shanghai Bluepha Microbiology Technology Co., Ltd. (CN) 2026-04-08 EP claimed
US-20240421372-A1 SPENT SECONDARY BATTERY CATHODE REGENERATION SOLUTION AND CATHODE REGENERATION METHOD USING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2024-12-19 US claimed
WO-2024245225-A1 POLYHYDROXYALKANOATE COMPOSITION, POLYHYDROXYALKANOATE MOLDED ARTICLE AND PREPARATION METHOD THEREFOR 上海蓝晶微生物科技有限公司 2024-12-05 WO claimed
CN-117209980-B Polyhydroxyalkanoate composition, polyhydroxyalkanoate molded body and preparation method of polyhydroxyalkanoate molded body 北京蓝晶微生物科技有限公司 2024-04-30 CN claimed
CN-117209980-A Polyhydroxyalkanoate composition, polyhydroxyalkanoate molded body and preparation method of polyhydroxyalkanoate molded body 北京蓝晶微生物科技有限公司 2023-12-12 CN claimed
WO-2006119283-A2 ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE YU RUEY J (US) 2006-11-09 WO claimed
US-20060251597-A1 ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE YU RUEY J 2006-11-09 US claimed
EP-1712227-A1 Amino diols useful in the treatment of Alzheimer's disease Elan Pharmaceuticals, Inc. (US) 2006-10-18 EP claimed
US-20050080141-A1 Amino diols useful in the treatment of alzheimer's disease SCHOSTAREZ HEINRICH J (US) 2005-04-14 US claimed
EP-1448177-A1 AMINO DIOLS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-08-25 EP claimed
WO-2003043618-A2 AMINO DIOLS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2003-05-30 WO claimed
US-20250009621-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER L'OREAL (FR) 2025-01-09 US disclosed
WO-2025006991-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER L'OREAL (FR) 2025-01-02 WO disclosed
US-20240421372-A1 SPENT SECONDARY BATTERY CATHODE REGENERATION SOLUTION AND CATHODE REGENERATION METHOD USING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2024-12-19 US disclosed
WO-2024245225-A1 POLYHYDROXYALKANOATE COMPOSITION, POLYHYDROXYALKANOATE MOLDED ARTICLE AND PREPARATION METHOD THEREFOR 上海蓝晶微生物科技有限公司 2024-12-05 WO disclosed
EP-0230266-A2 Functionalized peptidyl aminodiols and -triols ABBOTT LABORATORIES (US) 1987-07-29 EP disclosed
EP-0229667-A2 Peptidylaminodiols ABBOTT LABORATORIES (US) 1987-07-22 EP disclosed
EP-0210030-A2 Lubricating oil compositions containing novel combination of stabilizers PETRO CANADA INC (CA) 1987-01-28 EP disclosed
EP-0190322-A1 PROCESS FOR THE PRODUCTION OF AMINO COMPOUNDS FROM HYDROXYL COMPOUNDS. DIAMALT AG (DE) 1986-08-13 EP disclosed
WO-1986001502-A1 PROCESS FOR THE PRODUCTION OF AMINO COMPOUNDS FROM HYDROXYL COMPOUNDS DIAMALT AKTIENGESELLSCHAFT (DE) 1986-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250009621-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER EBP, ADH1A, ADH1C KMT2A 2260/4885ATM 1838/4885ALDH1A1 119/4885
US-20050080141-A1 Amino diols useful in the treatment of alzheimer's disease BACE1, BACE2, APP KMT2A 3385/4885ATM 3256/4885ALDH1A1 1048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.